(Q39934238)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18825742%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

title

Freeze-and-thaw-disrupted tumour cells impair the responsiveness of DC to TLR stimulation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18825742%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18825742%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

author name string

Iñigo Tirapu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18825742%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Martin Kreutz

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18825742%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Hayley McLinden

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18825742%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Sandra S Diebold

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18825742%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

language of work or name

English

0 references

publication date

1 October 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18825742%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Immunology

15 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18825742%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18825742%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18825742%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

2740-2750

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18825742%20AND%20SRC:MED&resulttype=core&format=json

Tumor-associated transforming growth factor-beta and interleukin-10 contribute to a systemic Th2 immune phenotype in pancreatic carcinoma patients

15 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838284

Dendritic cells capture killed tumor cells and present their antigens to elicit tumor-specific immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838284

Tolerance, danger, and the extended family

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838284

Phosphatidylserine regulates the maturation of human dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838284

Polymorphonuclear neutrophil-derived ectosomes interfere with the maturation of monocyte-derived dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838284

Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838284

Interaction between phosphatidylserine and the phosphatidylserine receptor inhibits immune responses in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838284

Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838284

Inhibitory effects of apoptotic cell ingestion upon endotoxin-driven myeloid dendritic cell maturation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838284

The use of dendritic cells in cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838284

7 January 2021

Dendritic cells as therapeutic vaccines against cancer

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838284

7 January 2021

Escape from immunotherapy: possible mechanisms that influence tumor regression/progression.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838284

7 January 2021

High levels of transforming growth factor beta 1 in patients with colorectal cancer: association with disease progression

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838284

7 January 2021

Increased interleukin-10 serum levels in patients with solid tumours.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838284

7 January 2021

Effect of interleukin-10 on dendritic cell maturation and function

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838284

7 January 2021

Vaccination of patients with cutaneous T-cell lymphoma using intranodal injection of autologous tumor-lysate–pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838284

7 January 2021

Durable complete clinical responses in a phase I/II trial using an autologous melanoma cell/dendritic cell vaccine

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838284

7 January 2021

Death-defying immunity: do apoptotic cells influence antigen processing and presentation?

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838284

7 January 2021

Natural endogenous adjuvants.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838284

7 January 2021

Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838284

7 January 2021

Molecular identification of a danger signal that alerts the immune system to dying cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838284

7 January 2021

Immunosuppressive effects of apoptotic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838284

7 January 2021

Apoptosis or necrosis for tumor immunotherapy: what's in a name?

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838284

7 January 2021

Natural adjuvants: endogenous activators of dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838284

7 January 2021

Release of chromatin protein HMGB1 by necrotic cells triggers inflammation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838284

7 January 2021

Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838284

7 January 2021

Toll-like receptors and dendritic cells: for whom the bug tolls

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838284

7 January 2021

Toll-like receptor control of the adaptive immune responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838284

7 January 2021

Toll-like receptor 3 promotes cross-priming to virus-infected cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838284

7 January 2021

The CD8+ dendritic cell subset selectively endocytoses dying cells in culture and in vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838284

7 January 2021

Cross-presentation of cell-associated antigens by CD8alpha+ dendritic cells is attributable to their ability to internalize dead cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838284

7 January 2021

Phosphatidylserine-specific receptor contributes to TGF-beta production in macrophages through a MAP kinase, ERK.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838284

7 January 2021

Artificial phosphatidylserine liposome mimics apoptotic cells in inhibiting maturation and immunostimulatory function of murine myeloid dendritic cells in response to 1-chloro-2,4-dinitrobenze in vitro

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838284

7 January 2021

Lipoxin-mediated inhibition of IL-12 production by DCs: a mechanism for regulation of microbial immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838284

7 January 2021

Exposure of anionic phospholipids serves as anti-inflammatory and immunosuppressive signal--implications for antiphospholipid syndrome and systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838284

7 January 2021

RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838284

7 January 2021

Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838284

7 January 2021

Endogenous ligands of Toll-like receptors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838284

7 January 2021

Identification of a key pathway required for the sterile inflammatory response triggered by dying cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838284

7 January 2021

Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838284

7 January 2021

Calreticulin exposure dictates the immunogenicity of cancer cell death

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838284

7 January 2021

Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838284

7 January 2021

Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838284

7 January 2021

Lipoxins: endogenous regulators of inflammation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838284

7 January 2021

Parasite-induced lipoxin A4 is an endogenous regulator of IL-12 production and immunopathology in Toxoplasma gondii infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838284

7 January 2021

Anti-inflammatory actions of lipoxin A4 and aspirin-triggered lipoxin are SOCS-2 dependent

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838284

7 January 2021

Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838284

7 January 2021

Recognition ligands on apoptotic cells: a perspective

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838284

7 January 2021

Clearance of apoptotic cells: getting rid of the corpses.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838284

7 January 2021

Phosphatidylserine (PS) induces PS receptor-mediated macropinocytosis and promotes clearance of apoptotic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838284

7 January 2021

Inhibition of phosphatidylserine recognition heightens the immunogenicity of irradiated lymphoma cells in vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838284

7 January 2021

Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838284

7 January 2021

Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838284

7 January 2021

Identifiers

DOI

10.1002/EJI.200838284

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18825742%20AND%20SRC:MED&resulttype=core&format=json

release_rhiv6wbwz5fp5py63lbp27iyhe

15 January 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rhiv6wbwz5fp5py63lbp27iyhe

24 November 2022

mapped directly with Wikidata item

1 reference